NCT01441986View on ClinicalTrials.gov

Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Dextromethorphan hydrobromide

Dextromethorphan hydrobromide•1 H2O; 30 mg; hard capsules; single, oral dose.

DRUG

Amantadine

Amantadine hydrochloride 100 mg; tablets; single, oral dose.

DRUG

Pacebo 1 (placebo for Amantadine)

Talets for oral use; single dose.

DRUG

Placebo 2 (fo Dextromethorphan)

Capsles for oral administration; single dose.

Trial Locations (1)

41460

Profil Institute for Metabolic Research, Neuss

All Listed Sponsors
collaborator

Heinrich-Heine University, Duesseldorf

OTHER

lead

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

NCT01441986 - Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects | Biotech Hunter | Biotech Hunter